Hudson Bay Capital Management
CDLX icon

Hudson Bay Capital Management’s Cardlytics CDLX Stock Holding History

Hudson Bay Capital Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,248
Closed -$20.5K – 1296
2025
Q2 		$20.5K Buy
+1,248
New +$21.6K ﹤0.01% 1307
2020
Q3 		– Sell
-2,500
Closed -$1.75M – 558
2020
Q2 		$1.75M Buy
+2,500
New +$1.44M 0.03% 329
2020
Q1 		– Sell
-2,180
Closed -$1.37M – 509
2019
Q4 		$1.37M Sell
2,180
-1,570
-42% -$768K 0.03% 310
2019
Q3 		$1.26M Sell
3,750
-6,250
-63% -$2M 0.03% 296
2019
Q2 		$2.6M Sell
10,000
-14,799
-60% -$2.96M 0.06% 246
2019
Q1 		$4.1M Buy
+24,799
New +$4.03M 0.05% 316

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Hudson Bay Capital Management's CDLX Position: Q3 2025 in Review

Hudson Bay Capital Management sold out of Cardlytics (CDLX) in Q3 2025, closing a stake of 1,248 shares — an estimated $20.5K sold.

Hudson Bay Capital Management first reported a position in CDLX in Q1 2019 and held it in 6 quarters. The position peaked at $4.1M in Q1 2019. 81 funds tracked by Wall St. Rank hold CDLX as of Q3 2025.

  • Hudson Bay Capital Management reported no remaining Cardlytics position as of Q3 2025 after selling out during the quarter.
  • Hudson Bay Capital Management sold 1,248 Cardlytics shares in Q3 2025, an estimated $20.5K.
  • Hudson Bay Capital Management first reported a position in Cardlytics in Q1 2019 and held it in 6 quarters.
  • Hudson Bay Capital Management's Cardlytics position peaked at $4.1M in Q1 2019.
  • 81 funds tracked by Wall St. Rank held Cardlytics as of Q3 2025.

Based on Hudson Bay Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.